Literature DB >> 28968293

Standardizing Descemet Membrane Endothelial Keratoplasty Graft Preparation Method in the Eye Bank-Experience of 527 Descemet Membrane Endothelial Keratoplasty Tissues.

Mohit Parekh1, Mattia Baruzzo, Elisa Favaro, Davide Borroni, Stefano Ferrari, Diego Ponzin, Alessandro Ruzza.   

Abstract

PURPOSE: To share the experience and provide a standardized protocol for Descemet membrane endothelial keratoplasty (DMEK) graft preparation.
METHODS: A retrospective study based on 527 prestripped DMEK tissues that were prepared between 2014 and 2017. The experience of using different instruments and techniques has been described, and a standardized technique for preparing DMEK grafts has been identified. The tissues in general were prepared by superficially tapping the endothelial side with a Moria trephine (9.5 mm diameter). The plane of cleavage was identified using a cleavage hook, and the DMEK graft was deadhered from the trephined site throughout the circumference for ease of excising the graft. The DMEK graft was peeled using either one or multiple quadrant methods depending on the challenges faced during excision. The graft was finally marked with the letter "F" to identify the orientation during surgery. Data on endothelial cell loss (ECL) and challenging cases were observed, monitored, and recorded during this period.
RESULTS: Less than 1 percent trypan blue-positive cells with tissue wastage of <6% was observed during the study period. Our standardized stripping technique has resulted in an overall ECL of 4.6%. Marking Descemet membrane showed 0.5% cell mortality.
CONCLUSIONS: Standardizing DMEK technique using specific tools and simple techniques would help new surgeons to decide the instruments and improve their tissue preparation skills also in challenging cases such as previous cataract incisions or horseshoe-shaped tears, further reducing ECL or tissue wastage.

Entities:  

Mesh:

Year:  2017        PMID: 28968293     DOI: 10.1097/ICO.0000000000001349

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  6 in total

1.  Safety of Long-Term Storage and Shipping of Prestripped, Prestained, and Preloaded Descemet Membrane Endothelial Keratoplasty Tissue.

Authors:  Jason Hooton; Kyeong Hwan Kim; Stephen I Lentz; Nicholas Hicks; Kayla Jones; Kristen McCoy; Shahzad I Mian
Journal:  Cornea       Date:  2019-08       Impact factor: 2.651

2.  Comparison of clinical outcomes after precut DMEK with or without dextran-containing medium compared to standard DMEK: a prospective pilot study.

Authors:  Annekatrin Rickmann; Karl Boden; Silke Wahl; Andre Trouvain; Andre Schulz; Peter Szurman
Journal:  Int Ophthalmol       Date:  2021-10-21       Impact factor: 2.031

3.  Increasing Donor Endothelial Cell Pool by Culturing Cells from Discarded Pieces of Human Donor Corneas for Regenerative Treatments.

Authors:  Mohit Parekh; Vito Romano; Alessandro Ruzza; Stephen B Kaye; Diego Ponzin; Sajjad Ahmad; Stefano Ferrari
Journal:  J Ophthalmol       Date:  2019-07-21       Impact factor: 1.909

Review 4.  Evolution of therapies for the corneal endothelium: past, present and future approaches.

Authors:  Hon Shing Ong; Marcus Ang; Jodhbir Mehta
Journal:  Br J Ophthalmol       Date:  2020-07-24       Impact factor: 4.638

5.  Eye bank versus surgeon prepared DMEK tissues: influence on adhesion and re-bubbling rate.

Authors:  Vito Romano; Ahmed Kazaili; Luca Pagano; Kunal Ajit Gadhvi; Mitchell Titley; Bernhard Steger; Luis Fernández-Vega-Cueto; Alvaro Meana; Jesus Merayo-Lloves; Ponzin Diego; Riaz Akhtar; Hannah J Levis; Stefano Ferrari; Stephen B Kaye; Mohit Parekh
Journal:  Br J Ophthalmol       Date:  2020-10-30       Impact factor: 4.638

Review 6.  New Horizons in the Treatment of Corneal Endothelial Dysfunction.

Authors:  Carlos Rocha-de-Lossada; Rahul Rachwani-Anil; Davide Borroni; José-María Sánchez-González; Raquel Esteves-Marques; Fernando-Luis Soler-Ferrández; Jose-Antonio Gegúndez-Fernández; Vito Romano; Eitan Livny; Marina Rodríguez Calvo-de-Mora
Journal:  J Ophthalmol       Date:  2021-07-09       Impact factor: 1.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.